4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.79
0.00 (0.00%)
May 12, 2026, 10:21 AM EDT - Market open
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $564.06 million as of May 12, 2026. Its market cap has increased by 264.73% in one year.
Market Cap
564.06M
Enterprise Value
126.96M
1-Year Change
264.73%
Ranking
Category
Stock Price
$10.79
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $564.06M, a decrease of -2.81%. That is a compound annual growth rate of -0.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 564.06M | 31.63% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 600.87M |
| Altimmune | 600.08M |
| AgomAb Therapeutics NV | 599.84M |
| Prime Medicine | 585.20M |
| Ginkgo Bioworks Holdings | 566.36M |
| Avalo Therapeutics | 540.97M |
| Eikon Therapeutics | 538.68M |
| ProKidney | 534.47M |